Följ oss

Nyheter

ECB rule bending to pressure the Euro

Publicerad

den

ECB rule bending to pressure the Euro Markets have repriced the Euro lower, as the chance for a populist Presidential win from Le Pen’s Front Nationale

ETF Securities – ECB rule bending to pressure the Euro

Highlights

  • Markets have repriced the Euro lower, as the chance for a populist Presidential win from Le Pen’s Front Nationale (FN) has increased in recent weeks.
  • The Euro, beset by political uncertainty, has been unable to benefit from the uptick in the underlying economic environment and an improvement in investor positioning in the futures market.
  • Although European Central Bank (ECB) quantitative easing (QE) program appears at its limit, the central bank appears ready to deviate from its ‘capital key’ and buy bonds from more heavily indebted nations, in turn putting further pressure on the Euro later in 2017.

Politics repricing the Euro

Analysts have repriced consensus forecasts lower for the EUR/USD during 2017, as political uncertainty threatens to break-up the Eurozone. At the end of 2016, consensus forecasts centred around 1.07 by end Q1 2017, compared to just 1.04 currently. We expect that the Euro should end Q1 around 1.08 as political uncertainty fades.

(click to enlarge)

The Euro has been battered by political uncertainty and has been unable to benefit from the improvement in the underlying economic environment. The Bloomberg Eurozone Economic Surprise Index suggests that the Euro could, in the absence of the ECB’s QE activities and the current uncertainty surrounding the political environment, be significantly higher against the USD.

Although populism and an increasingly insular voter attitude is a distinct similarity between the US and the Eurozone, the result for the currency could be a stark contrast. After vowing to bring back the French Franc, the potential for FN’s Le Pen to win the French election could prompt the Euro to move to parity against the US Dollar, a contrasting result compared to the US Dollar strength after the Trump Presidential victory. Nonetheless, EUR/USD parity on the back of a Le Pen victory is not our base case.

Economics drives policy differences

There are also other differences on an economic level between the US and Europe: unemployment across the Eurozone remains elevated, and excess spare capacity is likely to keep wage growth muted for some time. With excess labour market capacity, there is unlikely to be the pressure on core inflation that we expect to occur in the US later in 2017.

(click to enlarge)

However, inflation expectations have been rising on a global basis. The unwind of oil price effects has pushed headline prices higher, even beyond our bullish view and well beyond consensus expectations for the Eurozone. Eurozone inflation reached the highest level since March 2013, and now is in line with the ‘close to or below’ the 2.0% ECB target. Importantly inflation is unlikely to spike above the central bank’s target in coming months, and the ECB will ‘look through recent upturns in headline inflation’.

ECB nearing its limit

While the US Federal Reserve is taking a hawkish approach, the ECB is firmly in accommodative support mode with monetary policy.

(click to enlarge)

The ECB’s balance sheet has never been larger. However, the ECB is nearing the limit of its QE activities, with growth in its balance sheet fading. However, there are signs that the central bank could move outside the current scope of the asset purchase scheme to once again boost its balance sheet and the Eurozone money supply.

(click to enlarge)

Although the Euro should benefit if the ECB was able to cease its bond buying without any significant dislocations in interest rate markets by year-end, the potential for fresh policy pressure has weighed on the common currency.

The ECB’s latest Account of the monetary policy meeting noted the potential for the central bank to make ‘limited and temporary deviations’ from its capital key. This suggests the possibility of moving away from a broad GDP based bond buying scheme towards a debt weighted scheme. Such a move would advantage more heavily indebted nations such as Italy, but pressure the Euro in H2 2017.

What are markets pricing?

Futures market positioning has rebounded from extremely depressed levels, but investors remain net short of the Euro. However, the Euro is more depressed than what the historical relationship indicates. In contrast, options market pricing is highlighting the Euro is expected to be the second worst performer against the USD in the G10. Options pricing is the most pessimistic about the Euro’s valuation since June 2016.

(click to enlarge)

We expect the Euro to strengthen to around 1.08 in coming months as it becomes more apparent that Le Pen’s FN party is unlikely to win the French Presidency. Despite this volatility will remain, and further ECB asset purchases and ‘rule bending’ could see the Euro move back toward current levels in H2 2017.

Important Information

The analyses in the above tables are purely for information purposes. They do not reflect the performance of any ETF Securities’ products . The futures and roll returns are not necessarily investable.

General

This communication has been provided by ETF Securities (UK) Limited (“ETFS UK”) which is authorised and regulated by the United Kingdom Financial Conduct Authority (the “FCA”).

This communication is only targeted at qualified or professional investors

Fortsätt läsa
Annons
Klicka för att kommentera

Skriv en kommentar

Din e-postadress kommer inte publiceras. Obligatoriska fält är märkta *

Nyheter

A pro-crypto agenda is underway

Publicerad

den

• Trump’s crypto ally now leads the SEC, signaling the potential for a pro-crypto agenda • Bitcoin isn’t just for HODLing anymore, thanks to Babylon • The Dogecoin story: The emerging “intrinsic value
  • Trump’s crypto ally now leads the SEC, signaling the potential for a pro-crypto agenda
  • Bitcoin isn’t just for HODLing anymore, thanks to Babylon
  • The Dogecoin story: The emerging “intrinsic value”

Trump’s crypto ally now leads the SEC, signaling the potential for a pro-crypto agenda

Paul Atkins’ appointment as SEC Chair marks a significant turning point for cryptocurrency regulation in the United States. The cryptocurrency market embraced him, with both Bitcoin and Ethereum rallying up to 9% and 14% respectively in the immediate aftermath. Given Atkins’ background in the crypto space, the industry has welcomed his confirmation and anticipates that he may expedite the approval of several pending projects.

Bitcoin isn’t just for HODLing anymore, thanks to Babylon

Bitcoin is known for being one of the most secure blockchains out there. Now, a new project called Babylon is making waves by tapping into Bitcoin’s rock-solid security and bringing the staking feature to the Bitcoin world. Learn more about Bitcoin staking and its importance.

The Dogecoin story: The emerging “intrinsic value”

Dogecoin may have started as a meme, but it’s now a serious player in digital payments, offering fast, low-cost transactions to a passionate community driving real-world impact and innovation. The chart below underscores that real-world usage: it shows that cumulative transactions on the Dogecoin blockchain have surged over the past two years, effectively tripling in volume, all while transaction costs have remained remarkably low.

Research Newsletter

Each week the 21Shares Research team will publish our data-driven insights into the crypto asset world through this newsletter. Please direct any comments, questions, and words of feedback to research@21shares.com

Disclaimer

The information provided does not constitute a prospectus or other offering material and does not contain or constitute an offer to sell or a solicitation of any offer to buy securities in any jurisdiction. Some of the information published herein may contain forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and that actual results may differ materially from those in the forward-looking statements as a result of various factors. The information contained herein may not be considered as economic, legal, tax or other advice and users are cautioned to base investment decisions or other decisions solely on the content hereof.

Fortsätt läsa

Nyheter

SPFS ETF investerar i globala hälsovårdsföretag

Publicerad

den

SPDR MSCI World Health Care UCITS ETF (SPFS ETF) med ISIN IE00BYTRRB94, strävar efter att spåra MSCI World Health Care-index. MSCI World Health Care-index spårar hälsovårdssektorn på de utvecklade marknaderna över hela världen (GICS-sektorklassificering).

SPDR MSCI World Health Care UCITS ETF (SPFS ETF) med ISIN IE00BYTRRB94, strävar efter att spåra MSCI World Health Care-index. MSCI World Health Care-index spårar hälsovårdssektorn på de utvecklade marknaderna över hela världen (GICS-sektorklassificering).

Den börshandlade fondens TER (total cost ratio) uppgår till 0,30 % p.a. ETFen replikerar resultatet av det underliggande indexet genom full replikering (köper alla indexbeståndsdelar). Utdelningarna i ETFen ackumuleras och återinvesteras.

SPDR MSCI World Health Care UCITS ETF är en stor ETF med tillgångar på 531 miljoner euro under förvaltning. Denna ETF lanserades den 29 april 2016 och har sin hemvist i Irland.

Fondens mål

Fondens investeringsmål är att följa resultatet för företag inom hälso- och sjukvårdssektorn, över utvecklade marknader globalt.

Indexbeskrivning

MSCI World Health Care 35/20 Capped Index mäter utvecklingen för globala aktier som klassificeras som fallande inom hälsovårdssektorn, enligt Global Industry Classification Standard (GICS).

Handla SPFS

SPDR MSCI World Health Care UCITS ETF (SPFS ETF) är en europeisk börshandlad fond. Denna fond handlas på flera olika börser, till exempel Deutsche Boerse Xetra och London Stock Exchange.

Det betyder att det går att handla andelar i denna ETF genom de flesta svenska banker och Internetmäklare, till exempel DEGIRONordnet, Aktieinvest och Avanza.

Börsnoteringar

BörsValutaKortnamn
gettexEURSS49
Borsa ItalianaEURWHEA
Euronext AmsterdamEURWHEA
London Stock ExchangeUSDWHEA
London Stock ExchangeGBPHEAW
SIX Swiss ExchangeUSDWHEA
XETRAEURSPFS

Största innehav

VärdepapperVikt %
Eli Lilly and Company9,43%
Novo Nordisk A/S Class B5,97%
UnitedHealth Group Incorporated5,88%
Johnson & Johnson4,56%
Merck & Co. Inc.4,14%
AbbVie Inc.3,77%
AstraZeneca PLC3,11%
Novartis AG2,76%
Thermo Fisher Scientific Inc.2,65%
Roche Holding Ltd Dividend Right Cert.2,47%

Innehav kan komma att förändras

Fortsätt läsa

Nyheter

Slakten av Magnificent 7 aktierna

Publicerad

den

De amerikanska aktier som kollektivt går under namnet Mag7, också kända som Magnificent 7 aktierna har förlorat 4,4 biljoner dollar i marknadsvärde sedan toppen i december.

De amerikanska aktier som kollektivt går under namnet Mag7, också kända som Magnificent 7 aktierna har förlorat 4,4 biljoner dollar i marknadsvärde sedan toppen i december.

Detta är nästan dubbelt så mycket som värdet på den tyska aktiemarknaden. Dessa aktier återspeglar ~29 % av S&P 500-börsvärdet, en minskning från rekordhöga 34 %.

Vi skrev nyligen en artikel om tyska utdelningsaktier som du finner här

För den som letar efter investeringar i Tyskland klicka här

Källa: Global Markets Investor @GlobalMktObserv

Fortsätt läsa

21Shares

Prenumerera på nyheter om ETFer

* indicates required

21Shares

Populära